Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IBB vs MAGS: how they differ
IBB and MAGS hold 0% of their weight in the same names, and IBB returned more over the year.
iShares Biotechnology ETF and Roundhill Magnificent Seven ETF.
What they hold in common
By the books each fund has filed, IBB and MAGS hold 0% of their money in the same securities at the same weight.
| Only in IBB | Only in MAGS |
|---|---|
| Vertex Pharmaceuticals, Inc. 8.09% | TREASURY BILL 65.41% |
| Amgen, Inc. 7.84% | Roundhill Ultra Short Duration 8.06% |
| Gilead Sciences, Inc. 6.85% | NVIDIA Corp 4.15% |
| Regeneron Pharmaceuticals, Inc. 4.91% | Apple Inc 4.12% |
| Argenx SE 3.76% | Amazon.com Inc 4.11% |
| Alnylam Pharmaceuticals, Inc. 3.12% | Tesla Inc 4.07% |
| Natera, Inc. 2.89% | Microsoft Corp 3.62% |
| Revolution Medicines, Inc. 2.78% | Meta Platforms Inc 3.59% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| IBB iShares Biotechnology ETF | MAGS Roundhill Magnificent Seven ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | Roundhill |
| What it is | Biotechnology | Magnificent Seven |
| Total return, 1 year | +41.5% | +14.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +24.0 pts | −3.1 pts |
| Expense ratio | 0.44% | 0.30% |
| Already in the S&P 500 | 35.6% | 26.5% |
| Holdings | 248 | 9 |
IBB in plain words
IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.
MAGS in plain words
MAGS is an index equity fund tracking the Magnificent Seven. Over the year to Sep 11, 2026 it returned +14.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.30% a year. By its holdings filed for Jun 30, 2026, 26% of the fund by weight is stocks the S&P 500 also holds, across 9 positions, with the top ten at 100.0%.
Questions people ask
- Which returned more over the last year, IBB or MAGS?
- In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and MAGS returned +14.4%, so IBB returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IBB or MAGS?
- IBB charges 0.44% a year and MAGS charges 0.30%, so MAGS is cheaper. Fees come from each fund's prospectus.
- How much do IBB and MAGS overlap with the S&P 500?
- By their latest filed holdings, 36% of IBB and 26% of MAGS by weight is stocks the S&P 500 already holds. Between the two funds, 0% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IBB against MAGS, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-MAGS Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources